课题基金 / 基金详情

Development of new gene therapy for treatment of atherosclerosis using anti-apoptotic genes

Development of new gene therapy for treatment of atherosclerosis using anti-apoptotic genes
开发利用抗凋亡基因治疗动脉粥样硬化的新基因疗法
批准号:
12670678
负责人:
SUGANO Masahiro
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SUGANO Masahiro的其他基金

相关文献

中文摘要
翻译
1)转染sTNFRI载体的人脐静脉内皮细胞的生长速度也明显高于对照组。与对照组相比,转染sTNFRI载体的HUVEC条件培养液中sTNFRI的积累量显著增加。转染sTNFRI载体的人脐静脉内皮细胞不仅增加了sTNFRI,而且阻止了sTNFRI从TNFRI中脱落。转染sTNFRI载体的人脐静脉内皮细胞与对照载体相比,其诱导的核小体断裂也被显著阻止。2)与oxLDL共同孵育人脐静脉内皮细胞后,LOX-1基因表达水平和CPP32蛋白水解酶活性显著升高,并诱导细胞凋亡。在oxLDL孵育前用硝苯地平预先孵育HUVEC可显著抑制LOX-1mRNA水平和CPP32样蛋白酶活性的升高,并呈剂量依赖关系。这些结果表明,硝苯地平通过降低LOX-1mRNA水平和CPP32样蛋白酶活性来阻断导致内皮细胞凋亡的自杀途径。3)我们报道了将sTNFRI表达载体DNA直接注射到心肌中减少实验性大鼠急性心肌梗死的梗塞范围。经sTNFRI表达载体DNA处理后,心肌组织中的肿瘤坏死因子-α生物活性降低,心肌细胞凋亡率降低。提示sTNFRI抗肿瘤坏死因子-α治疗可作为治疗急性心肌梗死的新策略。
英文摘要
1) Growth of HUVEC transfected with sTNFRI vector also increased significantly compared to those transfected with control vector. Accumulation of sTNFRI significantly increased in conditioned medium from HUVEC transfected with sTNFRI vector compared to those transfected with control vector. HUVEC transfected with sTNFRI vector not only increased sTNFRI but also prevented shedding of sTNFRI from TNFRI. The TNF-a-induced internucleosomic fragmentation was also significantly prevented in HUVEC transfected with sTNFRI vector compared to those transfected with control vector.2) The incubation of HUVEC with oxLDL increased LOX-1 mRNA levels and CPP32-like protease activity, and induced apoptosis. Preincubation of HUVEC with nifedipine before incubation with oxLDL significantly suppressed the increase in LOX-1 mRNA levels and CPP32-like protease activity, preventing (7)___ in a dose-dependent manner. These results suggest that nifedipine blocks the suicide pathway leading to the apoptosis of endothelial cells by decreasing LOX-1 mRNA levels and CPP32-like protease activity.3) Here we report that direct injection of a sTNFRI expression plasmid DNA to the myocardium reduces infarct size in experimental rat AMI. Treatment with sTNFRI expression plasmid DNA reduced the TNF-alpha bioactivity in the myocardium and the apoptosis of cardiomyocytes. These findings suggest that the anti-TNF-alpha therapy by sTNFRI can be a new strategy for treatment of AMI.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Masutomo K., Makino N., Sugano M., Fushiki S.: "Effects of Losartan on the Collagen Degradative Enzymes in Hypertrophic and Congestive types of Cardiomyopathic Hamsters"Mol Cell Biochem.. 224. 19-27 (2001)
Masutomo K.、Makino N.、Sugano M.、Fushiki S.:“氯沙坦对肥厚型和充血型心肌病仓鼠胶原蛋白降解酶的影响”Mol Cell Biochem.. 224. 19-27 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroyoshi Hirayama, Masahiro Sugano, Nobuyuki Abe, Hidetoshi Yonemochi, Naoki Makino: "Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic funciton in normotensive diabetic patients"Int J. Cardiol. 77. 75-79 (2001)
Hiroyoshi Hirayama、Masahiro Sugano、Nobuyuki Abe、Hidetoshi Yonemochi、Naoki Makino:“曲格列酮是一种抗糖尿病药物,可改善血压正常的糖尿病患者的左心室质量和舒张功能”Int J. Cardiol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masahiro Sugano, Keiko Tsuchida, Hideharu Tomita, Naoki Makino: "Increased proliferation of endothelial cells with overexpression of soluble TNF-a receptor l gene"Atherosclerosis. (in press).
Masahiro Sugano、Keiko Tsuchida、Hideharu Tomita、Naoki Makino:“可溶性 TNF-α 受体 l 基因过度表达增加内皮细胞增殖”动脉粥样硬化。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroyoshi Hirayama,Masahiro Sugano,Nobuyuki Abe,Hidetoshi Yonemochi,Naoki Makino.: "Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients."Int J.Cardiol.. 77. 75-79 (2001)
Hiroyoshi Hirayyama、Masahiro Sugano、Nobuyuki Abe、Hidetoshi Yonemochi、Naoki Makino.:“曲格列酮是一种抗糖尿病药物,可改善血压正常的糖尿病患者的左心室质量和舒张功能。”Int J.Cardiol.. 77. 75-79 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Effect of siRNA targeting SHP-1 on angiogenesis in hindlimb ischemia
    • 批准号:
      18590817
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      SUGANO Masahiro
    • 依托单位:
    Therapy for ischemic vascular diseases using soluble TNF-alpha receptor 1 gene
    • 批准号:
      14570671
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2002
    • 负责人:
      SUGANO Masahiro
    • 依托单位:
    Study for lipid metabolism and atherosclerosis using antisense oligodeoxy nucleotides targeted to liver
    • 批准号:
      09670727
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1997
    • 负责人:
      SUGANO Masahiro
    • 依托单位: